777 related articles for article (PubMed ID: 26907882)
21. The diagnosis and treatment of non-alcoholic fatty liver disease.
Altinbas A; Sowa JP; Hasenberg T; Canbay A
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
[TBL] [Abstract][Full Text] [Related]
22. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
Pallayova M; Taheri S
Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
[TBL] [Abstract][Full Text] [Related]
23. Paediatric non-alcoholic fatty liver disease: an overview.
AlKhater SA
Obes Rev; 2015 May; 16(5):393-405. PubMed ID: 25753407
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic fatty liver disease - current status and future directions.
Demir M; Lang S; Steffen HM
J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351
[TBL] [Abstract][Full Text] [Related]
25. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery.
Selby LV; Ejaz A; Brethauer SA; Pawlik TM
Expert Opin Investig Drugs; 2020 Feb; 29(2):107-110. PubMed ID: 31986920
[No Abstract] [Full Text] [Related]
26. The pharmacological treatment of nonalcoholic fatty liver disease in children.
Crudele A; Panera N; Braghini MR; Balsano C; Alisi A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1219-1227. PubMed ID: 32981386
[TBL] [Abstract][Full Text] [Related]
27. Review of treatment options for nonalcoholic fatty liver disease.
Corrado RL; Torres DM; Harrison SA
Med Clin North Am; 2014 Jan; 98(1):55-72. PubMed ID: 24266914
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.
Lonardo A; Ballestri S; Targher G; Loria P
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):629-50. PubMed ID: 25327387
[TBL] [Abstract][Full Text] [Related]
29. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
30. NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?
Villela-Nogueira CA; Leite NC; Cardoso CR; Salles GF
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104526
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis.
Gisondi P; Barba E; Girolomoni G
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):282-7. PubMed ID: 26537011
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy.
Tomeno W; Kawashima K; Yoneda M; Saito S; Ogawa Y; Honda Y; Kessoku T; Imajo K; Mawatari H; Fujita K; Saito S; Hirayasu Y; Nakajima A
J Gastroenterol Hepatol; 2015 Jun; 30(6):1009-14. PubMed ID: 25619308
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
Williams T
FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.
Gracious BL; Bhatt R; Potter C
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):602-10. PubMed ID: 26447642
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management.
Başaranoğlu M; Örmeci N
Turk J Gastroenterol; 2014 Apr; 25(2):127-32. PubMed ID: 25003670
[TBL] [Abstract][Full Text] [Related]
36. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.
Amacher DE
Biomarkers; 2014 Nov; 19(7):541-52. PubMed ID: 25189636
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
38. Progression of liver disease in non-alcoholic fatty liver disease: a prospective clinicopathological follow-up study.
Chan WK; Ida NH; Cheah PL; Goh KL
J Dig Dis; 2014 Oct; 15(10):545-52. PubMed ID: 25060399
[TBL] [Abstract][Full Text] [Related]
39. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.
Mann JP; Goonetilleke R; McKiernan P
Arch Dis Child; 2015 Jul; 100(7):673-7. PubMed ID: 25633064
[TBL] [Abstract][Full Text] [Related]
40. Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease.
van Dijk AM; Schattenberg JM; Holleboom AG; Tushuizen ME
United European Gastroenterol J; 2021 Oct; 9(8):903-909. PubMed ID: 34609086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
